- Report
- May 2019
- 450 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- July 2023
- 132 Pages
Global
From €915EUR$950USD£787GBP
- Report
- May 2023
- 140 Pages
Global
From €5781EUR$5,999USD£4,972GBP
The Point-of-Care (POC) Coagulation Test market is a subset of the larger Point-of-Care Diagnostics market. It is focused on the development and sale of devices and tests that measure the clotting ability of a patient's blood. These tests are used to diagnose and monitor a variety of conditions, including deep vein thrombosis, pulmonary embolism, and stroke. POC Coagulation Tests are typically small, portable, and easy to use, allowing for quick results in a variety of settings. They are also cost-effective, making them attractive to healthcare providers.
Notable companies in the POC Coagulation Test market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Sysmex Corporation. Show Less Read more